Synergism of energy starvation and dextran-conjugated doxorubicin in the killing of multidrug-resistant KB carcinoma cells

Wing Lam, Hingleung Chan, Mengsu Yang, Shukhan Cheng, David W F Fong*

*Corresponding author for this work

Research output: Contribution to journalJournal articlepeer-review

9 Citations (Scopus)

Abstract

Here we report that 2-deoxyglucose/Na azide treatment and free/conjugated doxorubicin are synergistic in cell killing. As demonstrated by fluorescence confocal microscopy, KB-V1 cells retained more conjugated doxorubicin than free doxorubicin. Verapamil or 2-deoxyglucose/Na azide enhanced only the retention of the free drug and the small (< 70 kDa) conjugates, indicating that P-glycoprotein (P-gp) is not effective against large conjugates. Conjugated doxorubicin was excluded from nuclei. Initially both free and conjugated doxorubicin accumulated in cytoplasmic organelles. Upon 2-deoxyglucose/Na azide treatment, fluorescence labeling of organelles dissipated. Prolonged (24 h) incubation of conjugate-preloaded cells resulted in redistribution of some of the organelle-associated fluorescence to nuclei, suggesting decoupling. The appearance of free doxorubicin was confirmed by capillary electrophoresis. 2-Deoxyglucose/Na azide treatment also retarded decoupling. Our results suggest that energy starvation, in addition to increasing cellular retention of P-gp substrates, may affect cellular fate of conjugated drugs with a possible enhancing effect in cancer cell killing.

Original languageEnglish
Pages (from-to)171-178
Number of pages8
JournalAnti-Cancer Drugs
Volume10
Issue number2
DOIs
Publication statusPublished - 1999

Scopus Subject Areas

  • Oncology
  • Pharmacology
  • Pharmacology (medical)
  • Cancer Research

User-Defined Keywords

  • 2-Deoxyglucose/Na azide
  • Delayed decoupling
  • Dextran-conjugated doxorubicin
  • Multidrug resistance

Fingerprint

Dive into the research topics of 'Synergism of energy starvation and dextran-conjugated doxorubicin in the killing of multidrug-resistant KB carcinoma cells'. Together they form a unique fingerprint.

Cite this